Turkey: Food, Drugs, Healthcare, Life Sciences

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Latest Development Regarding Medicinal Product Names – Guideline Regarding The Naming Of Medicinal Products For Human Use Has Been Published
Turkey's pharmaceutical regulatory landscape has evolved with new naming guidelines for human medicinal products. The Turkish Medicines and Medical Devices Agency has established comprehensive procedures for assessing product name similarity, incorporating INN root analysis and automated screening systems. These regulations introduce structured evaluation criteria and appeal mechanisms that will reshape how pharmaceutical companies approach product naming in the Turkish market.
Turkey Healthcare
G+
Gun + Partners
Article
İlaç İsimlerine İlişkin Güncel Gelişme - Beşeri Tıbbi Ürünlerin İsimlendirmesine Dair Kılavuz Yayımlandı
Turkey's Pharmaceutical and Medical Devices Agency has published new guidelines establishing comprehensive naming standards for medicinal products, introducing systematic evaluation criteria and procedures for assessing name similarity and acceptability. The guidelines implement a scoring system through TIBAS that compares proposed names against existing databases, while also addressing international nonproprietary name conflicts and promotional language restrictions.
Turkey Healthcare
G+
Gun + Partners
Article
Geleneksel Bitkisel Tıbbi Ürünler Ruhsatlandırma Yönetmeliğinde Önemli Değişiklikler
2 Temmuz 2026 tarihli ve 33298 sayılı Resmî Gazete'de yayımlanan Geleneksel Bitkisel Tıbbi Ürünler Ruhsatlandırma Yönetmeliğinde Değişiklik Yapılmasına Dair Yönetmelik (“Değişiklik Yönetmeliği”) ile geleneksel bitkisel tıbbi ürünlerin ruhsatlandırılmasına ilişkin usul ve esaslarda önemli değişiklikler yapılmıştır.
Turkey Healthcare
OA
Ozbilen Aykut Attorney Partnership
Article
Major Amendments To The Regulation On The Authorisation Of Traditional Herbal Medicinal Products
The Regulation Amending the Regulation on the Authorisation of Traditional Herbal Medicinal Products (the “Amendment Regulation”), published in the Official Gazette dated 2 July 2026 and numbered 33298, introduces significant amendments to the procedures and principles governing the authorisation of traditional herbal medicinal products.
Turkey Healthcare
OA
Ozbilen Aykut Attorney Partnership
See more
Article
Criminal And Legal Consequences Of Adulteration And Imitation In Food Supplements
Acts of adulteration and imitation concerning food supplements can trigger criminal, administrative, and civil liability beyond mere violations of food legislation. This examination explores the regulatory framework, the critical distinction between imitation and adulteration, applicable sanctions, and relevant Court of Cassation decisions that shape legal implications for product safety, consumer health, and trademark protection.
Turkey Consumer
C
CBC Law Firm
Article
Latest Development Regarding Medicinal Product Names – Guideline Regarding The Naming Of Medicinal Products For Human Use Has Been Published
Turkey's pharmaceutical regulatory landscape has evolved with new naming guidelines for human medicinal products. The Turkish Medicines and Medical Devices Agency has established comprehensive procedures for assessing product name similarity, incorporating INN root analysis and automated screening systems. These regulations introduce structured evaluation criteria and appeal mechanisms that will reshape how pharmaceutical companies approach product naming in the Turkish market.
Turkey Healthcare
G+
Gun + Partners
See more
Article
İlaç İsimlerine İlişkin Güncel Gelişme - Beşeri Tıbbi Ürünlerin İsimlendirmesine Dair Kılavuz Yayımlandı
Turkey's Pharmaceutical and Medical Devices Agency has published new guidelines establishing comprehensive naming standards for medicinal products, introducing systematic evaluation criteria and procedures for assessing name similarity and acceptability. The guidelines implement a scoring system through TIBAS that compares proposed names against existing databases, while also addressing international nonproprietary name conflicts and promotional language restrictions.
Turkey Healthcare
G+
Gun + Partners
See more
Article
Latest Development Regarding Medicinal Product Names – Guideline Regarding The Naming Of Medicinal Products For Human Use Has Been Published
Turkey's pharmaceutical regulatory landscape has evolved with new naming guidelines for human medicinal products. The Turkish Medicines and Medical Devices Agency has established comprehensive procedures for assessing product name similarity, incorporating INN root analysis and automated screening systems. These regulations introduce structured evaluation criteria and appeal mechanisms that will reshape how pharmaceutical companies approach product naming in the Turkish market.
Turkey Healthcare
G+
Gun + Partners
See more